WO2004022221A1 - Preparation of microcapsules - Google Patents
Preparation of microcapsules Download PDFInfo
- Publication number
- WO2004022221A1 WO2004022221A1 PCT/IB2003/003764 IB0303764W WO2004022221A1 WO 2004022221 A1 WO2004022221 A1 WO 2004022221A1 IB 0303764 W IB0303764 W IB 0303764W WO 2004022221 A1 WO2004022221 A1 WO 2004022221A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microcapsules
- gelatin
- core material
- colloid
- hydrophobic core
- Prior art date
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 65
- 108010010803 Gelatin Proteins 0.000 claims abstract description 41
- 229920000159 gelatin Polymers 0.000 claims abstract description 41
- 235000019322 gelatine Nutrition 0.000 claims abstract description 41
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 41
- 239000008273 gelatin Substances 0.000 claims abstract description 39
- 238000005354 coacervation Methods 0.000 claims abstract description 25
- 239000000084 colloidal system Substances 0.000 claims abstract description 20
- 239000000796 flavoring agent Substances 0.000 claims abstract description 15
- 235000019634 flavors Nutrition 0.000 claims abstract description 15
- 230000002209 hydrophobic effect Effects 0.000 claims description 23
- 239000011162 core material Substances 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 9
- 239000012895 dilution Substances 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 6
- 239000003922 charged colloid Substances 0.000 claims description 5
- 238000010979 pH adjustment Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 239000000463 material Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 244000215068 Acacia senegal Species 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000205 acacia gum Substances 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 4
- 238000005191 phase separation Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- SCCDQYPEOIRVGX-UHFFFAOYSA-N eugenyl acetate Natural products COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000010945 base-catalyzed hydrolysis reactiony Methods 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- OIDPCXKPHYRNKH-UHFFFAOYSA-J chrome alum Chemical compound [K]OS(=O)(=O)O[Cr]1OS(=O)(=O)O1 OIDPCXKPHYRNKH-UHFFFAOYSA-J 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- -1 sum arabic Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
Definitions
- the present invention relates to the food and flavor industry. It concerns more particularly a complex coacervation process for the preparation of flavor-containing microcapsules which can be "Halal" certified.
- the process of the invention is based on the use of a type B gelatin as positively charged polymeric wall material.
- Coacervation also called aqueous phase separation, is a very well known technique for encapsulating hydrophobic liquids.
- a coacervation process allows to provide oil- containing microcapsules, the encapsulating material being a gelled hydrophilic colloid that is impervious to the oil and deposited evenly and densely about the oil as nucleus.
- the encapsulating material is a protein which may be complexed with another colloid having an opposite electric charge.
- a coacervation process essentially involves an aqueous protein solution which is manipulated by changing the physico-chemical environment (dilution and/or adjustment of pH) to result in phase separation of the protein from the solution to varying degrees depending on the molecular weight of the protein, its isoelectric point and compatibility with solvents.
- a coacervation process may be "simple" or "complex".
- the former designation is employed when a single protein is used to form a capsule wall as phase separation is taking place.
- the latter term designates the use of a second oppositely charged non-protein polymer to bring about phase separation.
- Complex coacervation method is widely practiced in commercial processes and has been well described in the literature. In particular US 2,800,457 and US 2,800,458 disclose complex coacervation in a very detailed manner.
- a coacervation process comprises four basic steps consisting of, respectively, emulsification, coacervation, wall formation and wall hardening.
- the wall surrounding the core material is, as mentioned above, constituted of two oppositely charged high molecular weight colloids.
- the positively charged colloid used is a gelatin, a functional protein derived from collagen by hydrolysis and subsequent extraction.
- gelatin a functional protein derived from collagen by hydrolysis and subsequent extraction.
- type A gelatin and type B gelatin. The primary difference between the two grades, arises from the manufacturing process.
- Type A gelatin has an isoelectric point comprised between 8.5 to 9.0 while type B gelatin has an isoelectric point varying from 4.8 to 5.5.
- type A gelatin has an isoelectric point comprised between 8.5 to 9.0 while type B gelatin has an isoelectric point varying from 4.8 to 5.5.
- coacervation that predominantly depends on the eletrokinetic stability of the system, such difference in isoelectric points can be critical for a successful encapsulation.
- the prior art related to complex coacervation almost always describe the use of type A gelatin as a cationic protein wall.
- gelatin provided by basic hydrolysis (type B) as a cationic protein wall, but to our l ⁇ iowledge, no example has ever really described such an embodiment and it has been established that the processes disclosed in the prior art do not allow the preparation of satisfactory microcapsules when type B gelatin is used as protein wall, in its cationic form.
- type B gelatin is sometimes mentioned in complex coacervation processes of the prior art as being used as polyanionic polymer i.e. in its electronegative form, in combination with a type A gelatin as positively charged colloid.
- gelatin uses, from a religious/ethnic standpoint. This includes "Kosher” and "Halal” status of gelatin.
- type A gelatin manufacturing process uses pig skin as starting material. As a consequence the microcapsules produced from this starting product cannot receive the "Halal” or "Kosher” status.
- Type B gelatin issued from cows or fishes, could receive either Halal or Kosher certification.
- no complex coacervation process disclosed in the prior art to date technically allows the preparation of microcapsules based on type B gelatin.
- Varaporn Buraphacheep Junyaprasert et al. describe in Drug Development and Industrial Pharmacy, 27(6), 561-566 (2001), a complex coacervation process for the encapsulation of Vitamin A, which uses type B gelatin in combination with gum acacia as wall materials.
- the process parameters there-disclosed are not optimized, in particular, the drug contents of the microcapsules do not exceed 50% w/w.
- the process according to the present invention allows to overcome the drawbacks observed in the prior art by providing an optimized complex coacervation process suitable for the preparation of microcapsules susceptible of being "Halal” certified, and containing up to 80% w/w of hydrophobic core material.
- the invention relates to a novel complex coacervation process, specially suitable for the preparation of high fix microcapsules encapsulating a hydrophobic core material, such microcapsules being susceptible of being incorporated into "Halal" certified foods or flavors.
- the process of the invention uses type B gelatin as polycationic colloid, in combination with a polyanionic material.
- the process parameters, such as pH, or the order of the processing steps, are critical for a successful encapsulation. More particularly, the process is characterized by the fact that the pH is adjusted before the emulsification or dispersion step, to a value between 3.0 and 4.7.
- the invention also relates to the microcapsules that are produced by this process. These microcapsules can be "Halal” certified and they comprise up to 80% by weight of hydrophobic core material.
- the invention also relates to a method for imparting, improving or modifying the organoleptic properties of a food composition, wherein microcapsules prepared by the process of the invention, are added to said composition, as well as food compositions comprising said microcapsules as an active ingredient.
- a first object of the present invention is therefore a process for the preparation of hydrophobic core material-containing microcapsules, which process comprises, in this order, the steps of : a) mixing solutions of a positively charged high molecular weight colloid and a negatively charged high molecular weight colloid ; b) adjusting the pH of the mixture obtained under a) to a value comprised between 3.0 and 4.7 ; c) emulsifying or dispersing a hydrophobic core material in the mixture ; d) subjecting the emulsion or dispersion obtained under c) to water dilution and/or pH adjustment to achieve coacervation ; e) cooling the coacervate obtained under d) to provide wall formation of microcapsules ; and f) adding a hardening agent ; said process being characterized by the fact that the positively charged high molecular weight colloid is a type B gelatin. What is meant by "high molecular weight” is typically a molecular weight comprised between 40 000
- hydrophobic core material encompass hydrophobic liquid materials which are usually subjected to encapsulation by coacervation, as well as solids or solids suspended in a hydrophobic liquid.
- the process is characterized by the fact that the positively charged high molecular weight colloid is a type B gelatin.
- type B gelatin in its cationic form is very unusual in this type of process. It implies that the pH of the solution is set to a value below its isoelectric point i.e. below 4.8-5.5.
- type B gelatin is obtained from basic hydrolysis of a collagen source (e.g. from cow or fish).
- the base catalyzed hydrolysis takes several days to be completed. Details of the process are well known by a skilled person in the art.
- any anionic polymer that reacts with the protein to form complex coacervates will suit the process of the invention.
- gum arabic, sodium alginate, agar, carrageenan, carboxymethyl cellulose, sodium polyacrylate or polyphosphoric acid are suitable anionic polymers for the purpose of the invention.
- the ratio between gelatin and the oppositely charged colloid is of 3 : 2.
- Step b) of the process of the invention consists in adjusting the pH of the mixture obtained under step a) to a value comprised between 3.0 and 4.7. This can be typically achieved by means of addition of lactic acid.
- This step is essential in the process of the invention, in terms of specific pH values, as well as from a process stage point of view. In fact, the adjustment is operated before the addition of the hydrophobic core material, contrary to what is disclosed in the processes of the prior art, wherein the pH is usually adjusted after emulsification or dispersion step. Now, in an unexpected manner, it turned out that the adjustment of the pH to a suitable value at this particular stage of the process, is responsible for an efficient wall formation of the microcapsules.
- a hydrophobic core material is emulsified or dispersed in the mixture.
- this core material may consist of a hydrophobic liquid, as well as of a solid or yet a solid dispersed in a hydrophobic liquid.
- the core material to be encapsulated is a liquid flavor ingredient or composition.
- These terms can define a variety of flavor materials of both natural and synthetic origin, currently used for the preparation of food compositions. They include single compounds or mixtures. Specific examples of such components may be found in the current literature, e.g. in Fenaroli's Handbook of Flavor Ingredients, 1975, CRC Press ; Synthetic Food Adjuncts, 1947 by M.B.
- Natural extracts can also be encapsulated into the system of the invention ; these include e.g. citrus extracts such as lemon, orange, lime, grapefruit or mandarin oils, or coffee, tea, mint, cocoa, vanilla or essentials oils of herbs or spices, amongst other.
- the proportion of hydrophobic core material is comprised between 35 and 90% by weight relative to the weight of gelatin used.
- the process of the invention is of course also suitable for the encapsulation of other core materials than flavoring ingredients, such as perfuming ingredients, pharmaceuticals or cosmetic ingredients.
- the following steps of the process are respectively coacervation by water dilution and/or pH adjustment, followed by the cooling of the coacervate to provide wall-formation.
- the cooling must allow to reach a temperature where the colloids do gel.
- the cooling rate is comprised between 0.25 and 0.5°C/min.
- a hardening agent is added in order to cross-link the wall formed around the hydrophobic core material.
- Typical examples of hardening agents suitable for the purpose of the invention include formaldehyde, acetaldehyde, glyoxal, glutaraldehyde, chrome alum and the like.
- Microcapsules susceptible of being obtained by a process according to the invention constitute another object of the invention.
- These delivery systems present the advantage of being potentially “Halal” certified, and can therefore be used for the flavoring of so-designated final consumer products.
- the microcapsules of the invention are very highly loaded in hydrophobic core material. More particularly, the microcapsules may contain up to 80% by weight of a hydrophobic core material, while the processes disclosed in the prior art only allowed to have up to 35% by weight of active ingredient in the capsules.
- the final products have a wall thickness and a morphology very satisfactory and comparable to that of microcapsules prepared starting from type A gelatin at same fix level, as revealed by microscopic pictures shown in figures 1 and 2.
- microcapsules produced by the process of the invention can be used in many kinds of applications in the field of foods and flavors. Therefore, food compositions comprising the microcapsules according to the invention together with other flavoring coingredients, are also objects of the present invention.
- Figures 1 and 2 are microscopic pictures at lOx magnification of complex coacervates prepared respectively with type A (Fig. 1) and type B (Fig. 2) gelatin as cationic polymers.
- Type B gelatin 250 Bloom, origin : SKW Biosystems, USA
- gum arabic cold pressed orange peel oil
- limonene eugenol
- octyl acetate acetate
- Several trials were made, varying the concentrations of colloids, the pH of the system, the amount of dilution water, the order of the process steps and the ratio between gelatin and gum arabic.
- Table 1 reports the amounts of ingredients used in each trial.
- Table 1 Amounts of gelatin, water, sum arabic, water, flavor and dilution water in the process of the invention in five trials
- microcapsules were prepared by a process comprising the basic steps of emulsification or dispersion, coacervation (water dilution), wall-forming (cooling) and cross-linking.
- the proportions of ingredients and/or the stage of pH adjustment in the process were changed.
- the colloid solutions were mixed at a temperature of 37-40°.
- the final temperature of the system was 22-24°.
- the pH was adjusted by addition of lactic acid.
- the cooling rate was comprised between 0.25 and 0.5 min. After cooling the batch to the final temperature, 0.14% by weight of glutaraldehyde solution (25%) were added to cross-link the protein wall.
- Trial #1 Components were mixed in the following order : the flavor (cold pressed orange peel oil) was emulsified in a mixture of gelatin solution and gum arabic solution. Dilution water was added. The batch pH was then adjusted from 4.64 to 2.82 in decrements but there was practically no wall formation.
- Trial #2 The trial was identical to trial 1, except for doubling the amount of dilution water. Trial was unsuccessful.
- Trial #3 Identical to trial #2 except that the concentrations of the colloid solutions were changed along with the ratio. Trial was unsuccessful.
- Trials #lto 3 demonstrate the essential character of the order in which the steps of the process of the invention are performed. When the pH is adjusted after the emulsification/dispersion step, no wall formation occurs.
- Trial #4 Identical to trial #1 in formulation. Order of addition was changed. After mixing the colloid solutions, pH was adjusted to 3.0 with lactic acid, prior to the addition of flavor oil. Excellent wall formation was observable. This trial proves the importance of the pH adjustment' stage in the process.
- Trial #5 Everything was done like in trial #4, except that the flavor consisted of a 60 : 20 : 20 mixture of limonene, eugenol and octyl acetate. Trial was successful.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003255982A AU2003255982A1 (en) | 2002-09-03 | 2003-08-21 | Preparation of microcapsules |
EP03793970A EP1549428A1 (en) | 2002-09-03 | 2003-08-21 | Preparation of microcapsules |
CA002497336A CA2497336A1 (en) | 2002-09-03 | 2003-08-21 | Preparation of microcapsules |
JP2004533737A JP2005537128A (en) | 2002-09-03 | 2003-08-21 | Microcapsule manufacturing method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/234,775 | 2002-09-03 | ||
US10/234,775 US7473467B2 (en) | 2002-09-03 | 2002-09-03 | Preparation of microcapsules |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004022221A1 true WO2004022221A1 (en) | 2004-03-18 |
Family
ID=31977466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2003/003764 WO2004022221A1 (en) | 2002-09-03 | 2003-08-21 | Preparation of microcapsules |
Country Status (7)
Country | Link |
---|---|
US (1) | US7473467B2 (en) |
EP (1) | EP1549428A1 (en) |
JP (1) | JP2005537128A (en) |
CN (1) | CN100377775C (en) |
AU (1) | AU2003255982A1 (en) |
CA (1) | CA2497336A1 (en) |
WO (1) | WO2004022221A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008142637A1 (en) * | 2007-05-21 | 2008-11-27 | Firmenich Sa | Large coacervated capsules |
US8088403B2 (en) | 2006-04-04 | 2012-01-03 | Firmenich Sa | Method for preparing microcapsules by coacervation |
WO2012001604A2 (en) | 2010-06-30 | 2012-01-05 | Firmenich Sa | Solid core coacervated capsules |
WO2012168144A1 (en) | 2011-06-07 | 2012-12-13 | Firmenich Sa | Core-shell capsules |
WO2013174921A1 (en) | 2012-05-24 | 2013-11-28 | Firmenich Sa | Hybrid coacervate capsules |
WO2016124746A1 (en) | 2015-02-06 | 2016-08-11 | Firmenich Sa | Microcapsules imparting intense vanilla odor note |
WO2017143174A1 (en) | 2016-02-18 | 2017-08-24 | International Flavors & Fragrances Inc. | Polyurea capsule compositions |
EP4124383A1 (en) | 2021-07-27 | 2023-02-01 | International Flavors & Fragrances Inc. | Biodegradable microcapsules |
EP4154974A1 (en) | 2021-09-23 | 2023-03-29 | International Flavors & Fragrances Inc. | Biodegradable microcapsules |
EP4209264A1 (en) | 2016-09-16 | 2023-07-12 | International Flavors & Fragrances Inc. | Microcapsule compositions stabilized with viscosity control agents |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040032036A1 (en) * | 2002-08-19 | 2004-02-19 | Anandaraman Subramaniam | Process for the preparation of flavor or fragrance microcapsules |
US8663690B2 (en) * | 2006-10-31 | 2014-03-04 | William Marsh Rice University | Method for nanoencapsulation |
JP2008206420A (en) * | 2007-02-23 | 2008-09-11 | Fuji Oil Co Ltd | Polyion complex film for preventing food moisture transport |
US9186640B2 (en) * | 2007-08-28 | 2015-11-17 | Pepsico, Inc. | Delivery and controlled release of encapsulated lipophilic nutrients |
US20100028503A1 (en) * | 2008-07-30 | 2010-02-04 | Jimbay Peter Loh | Simultaneous Multiple Acervation Process |
EP2292102A1 (en) * | 2009-09-02 | 2011-03-09 | Lipofoods, S.L. | Microcapsules containing salts for food products |
US9743688B2 (en) | 2010-03-26 | 2017-08-29 | Philip Morris Usa Inc. | Emulsion/colloid mediated flavor encapsulation and delivery with tobacco-derived lipids |
CN102441354A (en) * | 2011-10-27 | 2012-05-09 | 天津大学 | Preparation method for monochrome electrophoresis display microcapsules |
US20130251855A1 (en) * | 2012-03-21 | 2013-09-26 | Pepsico, Inc. | Aqueous product comprising oil-containing microcapsules and method for the manufacture thereof |
TWI605870B (en) * | 2012-10-25 | 2017-11-21 | 奇華頓公司 | Process |
CN109645555A (en) * | 2019-01-30 | 2019-04-19 | 湖北中烟工业有限责任公司 | A kind of preparation method and application for the fruity perfume (or spice) line in Novel heating not burning tobacco |
JP2021106507A (en) * | 2019-12-27 | 2021-07-29 | 小林製薬株式会社 | Gelatin-containing composition and moisture absorption suppressing method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3574132A (en) * | 1968-01-12 | 1971-04-06 | Benjamin Mosier | Process of encapsulating basic nitrogen compounds with alkali-precursor gelatin |
EP0385535A1 (en) * | 1989-02-27 | 1990-09-05 | The Procter & Gamble Company | Microcapsules containing hydrophobic liquid core |
US5672301A (en) * | 1992-08-20 | 1997-09-30 | Coletica | Method for fabricating microparticles in emulsion by modification of the chemical composition of the dispersed phase after emulsification |
US5922652A (en) * | 1992-05-05 | 1999-07-13 | Procter & Gamble | Microencapsulated oil field chemicals |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE530009A (en) * | 1953-06-30 | |||
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
CH563951A5 (en) * | 1972-02-03 | 1975-07-15 | Firmenich & Cie | |
US4460792A (en) * | 1981-09-07 | 1984-07-17 | Firmenich S.A. | Process for the preparation of delta- and epsilon-damascones |
EP0260472B1 (en) | 1986-09-19 | 1991-03-13 | Firmenich Sa | Method for the production of cycloaliphatic ketones |
US4900570A (en) * | 1988-06-20 | 1990-02-13 | Jac Creative Foods, Inc. | Shrimp forming process |
WO1993025302A1 (en) * | 1992-06-16 | 1993-12-23 | Fuji Oil Co., Ltd | Emulsifier, emulsifying composition and powdery composition |
CN1389882A (en) * | 2002-04-29 | 2003-01-08 | 广东南方宏明电子科技股份有限公司 | Manufacture of semiconductor ceramic capacitor with crystal interface layer |
-
2002
- 2002-09-03 US US10/234,775 patent/US7473467B2/en active Active
-
2003
- 2003-08-21 WO PCT/IB2003/003764 patent/WO2004022221A1/en active Application Filing
- 2003-08-21 AU AU2003255982A patent/AU2003255982A1/en not_active Abandoned
- 2003-08-21 JP JP2004533737A patent/JP2005537128A/en active Pending
- 2003-08-21 EP EP03793970A patent/EP1549428A1/en not_active Withdrawn
- 2003-08-21 CN CNB038207974A patent/CN100377775C/en not_active Expired - Lifetime
- 2003-08-21 CA CA002497336A patent/CA2497336A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3574132A (en) * | 1968-01-12 | 1971-04-06 | Benjamin Mosier | Process of encapsulating basic nitrogen compounds with alkali-precursor gelatin |
EP0385535A1 (en) * | 1989-02-27 | 1990-09-05 | The Procter & Gamble Company | Microcapsules containing hydrophobic liquid core |
US5922652A (en) * | 1992-05-05 | 1999-07-13 | Procter & Gamble | Microencapsulated oil field chemicals |
US5672301A (en) * | 1992-08-20 | 1997-09-30 | Coletica | Method for fabricating microparticles in emulsion by modification of the chemical composition of the dispersed phase after emulsification |
Non-Patent Citations (1)
Title |
---|
JUNYAPRASERT ET AL: "Effect of Process Variables on the Microencapsulation of Vitamin A Palmitate by Gelatin-Acacia Coacervation", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY., vol. 27, no. 6, 2001, NEW YORK, NY, US, pages 561 - 566, XP008025027, ISSN: 0363-9045 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088403B2 (en) | 2006-04-04 | 2012-01-03 | Firmenich Sa | Method for preparing microcapsules by coacervation |
WO2008142637A1 (en) * | 2007-05-21 | 2008-11-27 | Firmenich Sa | Large coacervated capsules |
WO2012001604A2 (en) | 2010-06-30 | 2012-01-05 | Firmenich Sa | Solid core coacervated capsules |
WO2012168144A1 (en) | 2011-06-07 | 2012-12-13 | Firmenich Sa | Core-shell capsules |
WO2013174921A1 (en) | 2012-05-24 | 2013-11-28 | Firmenich Sa | Hybrid coacervate capsules |
US10092023B2 (en) | 2012-05-24 | 2018-10-09 | Firmenich Sa | Hybrid coacervate capsules |
US10260022B2 (en) | 2015-02-06 | 2019-04-16 | Firmenich Sa | Microcapsules imparting intense vanilla odor note |
WO2016124746A1 (en) | 2015-02-06 | 2016-08-11 | Firmenich Sa | Microcapsules imparting intense vanilla odor note |
WO2017143174A1 (en) | 2016-02-18 | 2017-08-24 | International Flavors & Fragrances Inc. | Polyurea capsule compositions |
EP4209264A1 (en) | 2016-09-16 | 2023-07-12 | International Flavors & Fragrances Inc. | Microcapsule compositions stabilized with viscosity control agents |
EP4124383A1 (en) | 2021-07-27 | 2023-02-01 | International Flavors & Fragrances Inc. | Biodegradable microcapsules |
WO2023009514A1 (en) | 2021-07-27 | 2023-02-02 | International Flavors & Fragrances Inc. | Biodegradable microcapsules |
EP4154974A1 (en) | 2021-09-23 | 2023-03-29 | International Flavors & Fragrances Inc. | Biodegradable microcapsules |
WO2023049260A1 (en) | 2021-09-23 | 2023-03-30 | International Flavors & Fragrances Inc. | Biodegradable microcapsules |
Also Published As
Publication number | Publication date |
---|---|
CN100377775C (en) | 2008-04-02 |
US20040041306A1 (en) | 2004-03-04 |
JP2005537128A (en) | 2005-12-08 |
AU2003255982A1 (en) | 2004-03-29 |
EP1549428A1 (en) | 2005-07-06 |
CN1678388A (en) | 2005-10-05 |
CA2497336A1 (en) | 2004-03-18 |
US7473467B2 (en) | 2009-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7473467B2 (en) | Preparation of microcapsules | |
EP1531927B1 (en) | Process for the preparation of flavor or fragrance microcapsules | |
EP2588066B1 (en) | Solid core coacervated capsules | |
US10092023B2 (en) | Hybrid coacervate capsules | |
CA1060364A (en) | Encapsulation process utilizing microorganisms and products produced thereby | |
KR100418544B1 (en) | Encapsulated product | |
EP1551546A1 (en) | Complex coacervates containing whey proteins | |
US8465835B2 (en) | Capsules | |
JP2009532202A (en) | Method for producing microcapsules by coacervation | |
JP2013240787A (en) | Large coacervated capsule | |
JP2011036239A (en) | Novel preparation of enteric release system | |
NL1028383C2 (en) | Microcapsules. | |
KR101526689B1 (en) | Composition of biopolymer microcapsule and method of preparation | |
JPH11216354A (en) | Manufacture of micro-capsule | |
JPH053772A (en) | Emulsifying agent of oily component, emulsifying oily component, soup for dilution and production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1-2005-500316 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003793970 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2497336 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038207974 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004533737 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 339/KOLNP/2005 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003793970 Country of ref document: EP |